4-Bromoisoquinoline-1-carboxamide

Catalog No.: 
ACFNDH924
CAS No.: 
1089328-67-5
Molecular Formula: 
C10H7BrN2O
Molecular Weight: 
251.08
4-Bromoisoquinoline-1-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$175.00InquiryInquiry
1g97%$499.00InquiryInquiry
5g97%$2470.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Bromoisoquinoline-1-carboxamide
IUPAC Name4-bromoisoquinoline-1-carboxamide
Molecular FormulaC10H7BrN2O
Molecular Weight251.08
SMILESO=C(C1=NC=C(Br)C2=C1C=CC=C2)N
InChI KeyIRGPTLJPQGLHPS-UHFFFAOYSA-N
Synonym4-Bromoisoquinoline-1-carboxamide
CAS No.1089328-67-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACFNDH924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACBETZ782 route compound structure diagram
    ACBETZ7821512077-05-2In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACFNDH924 route product structure diagram
    ACFNDH9241089328-67-5
Inquiry

2. ACFNDH924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACFNDH924 route product structure diagram
    ACFNDH9241089328-67-5
Inquiry

3. ACFNDH924 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACFNDH924 route product structure diagram
    ACFNDH9241089328-67-5
Inquiry

Comments (0)